Guava Announces Funding Round of $2.4 Million
Guava is working to close the racial wealth gap and increase financial equity BROOKLYN, N.Y., July 26, 2022 /PRNewswire/ -- Guava, the premier ban...
Stay updated with breaking news from Cornell Tech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Guava is working to close the racial wealth gap and increase financial equity BROOKLYN, N.Y., July 26, 2022 /PRNewswire/ -- Guava, the premier ban...
Are you targeting Cornell University’s Johnson Graduate School of Management? The Cornell MBA application is now live, so it’s time to tackle those MBA essays. Cornell Johnson is a flexible…
Employing artificial intelligence to help improve outcomes for people with cardiovascular disease is the focus of a three-year, $15 million collaboration among Cornell Tech, the Cornell Ann S. Bowers College of Computing and Information Science (Cornell Bowers CIS) and NewYork-Presbyterian – with physicians from its affiliated medical schools Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons (Columbia University VP&S).
The partnership will focus on developing artificial-intelligence tools to treat heart failure and other cardiovascular conditions.
The idea is to add more noise to disrupt the signal. But making it work is complicated.